Prevision di Hansoh Pharmaceutical (3692)
Previson AI: 3692
L'AI e publiche un prezi obietîf pal prossim dì di trading, pe fin de setemane e pe fin dal mês. La variazion e ven mesurade dal ultin prezi. Chestis a son stimis statistichis, no conseis di investiment.
Presi tai ultins 6 mês
Premium al mostre i obietîfs di presis de AI par 1 dì, 1 setemane e 1 mês par cheste e par ogni altre azion.
Vierç Premium🔒 Storic des previsions
Il storic des previsions — ogni prevision passade a fianç dal cjiusurament efetîf — al è part di Premium.
Vierç PremiumSu cheste societât
Hansoh Pharmaceutical is among the top 30 pharmaceutical companies in China. The company manufactures medicines and has 20 years of experience in research for the treatment of diseases, including cancer, diabetes, and nervous system disorders. By the end of 2020, the company had carried out more than 50 national research and development projects and obtained over 300 invention patents in China and abroad. It owns R&D centers in Shanghai, Changzhou, and Lianyungang (China), as well as in Maryland (United States).
